TNF and inflammatory bowel disease: The timing of the antibody assessment in these studies may explain this discrepancy, for example, a longitudinal study in IBD patients showed a preserved antibody response at 3 weeks but a lower antibody titer at 6 months and 2 years in TNF inhibitor recipients vs. controls [91].